Drug Delivery and Supply Chain

InnovHeart announces first US Saturn transseptal TMVR system implant, reaching 15 patients globally

InnovHeart, a medical device company developing the Saturn Transseptal Transcatheter Mitral Valve Replacement (TMVR) System, today announces the successful...

Cipla announces exclusive partnership with Qilu Pharmaceutical for the licensing and supply of biosimilar to Keytruda (Pembrolizumab) in the US

Invagen Pharmaceuticals has entered into a strategic partnership with Qilu Pharmaceutical Co, for the exclusive licensing and supply of QL2107, a...

ENA Respiratory awarded Biointelect Venturer funding to support new study in asthma patients of INNA-051 nasal spray designed to protect against symptomatic viral respiratory infections

ENA Respiratory, a clinical-stage pharmaceutical company developing host defence enhancers for the prevention of complications associated with respiratory viral infections in at-risk...

Lubrizol targets drug delivery challenges at CPHI Milan

Lubrizol will showcase its portfolio of multifunctional excipients at CPHI Milan (6-8 October), and demonstrate how they solve diverse...

Aurora Cannabis furthers global medical cannabis growth with accretive acquisition of Internode Pharma and HAP Pharma

Aurora Cannabis, the Canadian-based leading global medical cannabis company, has acquired Internode Pharma, a licensed importer and wholesaler and HAP...

FUJIFILM Biotechnologies selected in FDA precheck pilot programme to advance US drug manufacturing

Fujifilm’s commercial-scale cell culture manufacturing facility in Holly Springs, North Carolina, has been selected as one of only seven...

Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across US, Europe and India

Samsung Biologics has launched a cash public tender offer to acquire 100% of PolyPeptide Group AG, a leading global...

Lonza expands strategic collaboration with leading US biopharmaceutical company

Lonza, the world’s leading contract development and manufacturing organisation (CDMO), has announced an expanded strategic collaboration with a leading...

NurExone signs exclusive US GMP manufacturing partnership with made scientific

NurExone Biologic Inc., and its US subsidiary, Exo-Top Inc., have signed a binding memorandum of understanding (MOU) with Made Scientific to establish...

RenovoRx announces first commercial clinical use of RenovoCath in sarcoma patient treatment, marking expansion of targeted drug-delivery device to other solid tumours

RenovoRx, a life sciences company developing innovative targeted oncology therapies and commercialising RenovoCath, a patented, FDA-cleared drug-delivery device, has announced...

EpilepsyGTx partners with ClearPoint Neuro to support targeted delivery of lead gene therapy in epilepsy

EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint Neuro, a global therapy-enabling company...

Liraglutide combination products incorporating Stevanato Group’s Alina pen injector received marketing authorisations in multiple European countries

Stevanato Group SpA, a leading global provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology...

Latest DDSC news